Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nicole Melong
Observed names:
Melong, Nicole,
N. Melong,
Nicole Melong (21786709)
Institutions:
Dalhousie University,
Children's Hospital of Eastern Ontario,
CHEO Research Institute
Observed institutions:
Dalhousie University,
University of Ottawa,
Children's Hospital of Eastern Ontario,
Izaak Walton Killam Health Centre,
CHEO Research Institute
ORCID:
0000-0002-0429-0944
Observed ORCID:
0000-0002-0429-0944
OpenAlex ID:
A5044027975
High-throughput Chemical Screening Identifies Focal Adhesion Kinase and Aurora Kinase B Inhibition as a Synergistic Treatment Combination in Ewing Sarcoma
2019
·
Sarah Wang
, Elizabeth E. Hwang
, et al.
·
Clinical Cancer Research
·
49
Humanized zebrafish enhance human hematopoietic stem cell survival and promote acute myeloid leukemia clonal diversity
2019
·
Vinothkumar Rajan
, Nicole Melong
, et al.
·
Haematologica
·
44
PDF
Radiation dose enhancement using gold nanoparticles with a diamond linear accelerator target: a multiple cell type analysis
2022
·
Olivia Piccolo
, John D. Lincoln
, et al.
·
Scientific Reports
·
35
PDF
The Zebrafish Xenograft Platform—A Novel Tool for Modeling KSHV-Associated Diseases
2019
·
Eric S. Pringle
, Jaime Wertman
, et al.
·
Viruses
·
31
PDF
The identification of dual protective agents against cisplatin-induced oto- and nephrotoxicity using the zebrafish model
2020
·
Jaime N Wertman
, Nicole Melong
, et al.
·
eLife
·
23
Enzalutamide inhibits testosterone-induced growth of human prostate cancer xenografts in zebrafish and can induce bradycardia
2017
·
Nicole Melong
, Shelby Steele
, et al.
·
Scientific Reports
·
19
PDF
In Vivo Validation of PAPSS1 (3′-phosphoadenosine 5′-phosphosulfate synthase 1) as a Cisplatin-sensitizing Therapeutic Target
2017
·
Ada W.Y. Leung
, Chansey J. Veinotte
, et al.
·
Clinical Cancer Research
·
15
Phloridzin docosahexaenoate, a novel flavonoid derivative, suppresses growth and induces apoptosis in T-cell acute lymphoblastic leukemia cells.
2017
·
Niroshaathevi Arumuggam
, Nicole Melong
, et al.
·
PubMed Central
·
15
Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
2025
·
Nadine Azzam
, Jamie I. Fletcher
, et al.
·
Cancer Research Communications
·
3
Proteomics and personalized PDX models identify treatment for a progressive malignancy within an actionable timeframe
2025
·
Georgina D Barnabas
, Tariq A Bhat
, et al.
·
EMBO Molecular Medicine
·
3
PDF
Zebrafish xenotransplantation: A versatile platform for cancer and stem cell translational research
2022
·
Nicole Melong
, Kim Kobar
, et al.
·
Elsevier eBooks
·
3
Tissue‐Engineered Disease Modeling of Lymphangioleiomyomatosis Exposes a Therapeutic Vulnerability to HDAC Inhibition
2023
·
Adam Pietrobon
, Julien Yockell‐Lelièvre
, et al.
·
Advanced Science
·
2
PDF
Abstract 1943: High-throughput chemical screening identifies Focal Adhesion Kinase and Aurora Kinase B inhibition as a synergistic treatment combination in Ewing sarcoma
2017
·
Brian Crompton
, Sarah Wang
, et al.
·
Cancer Research
·
2
A Humanized Zebrafish Transplant Model Expressing CXCL12 Provides an Enhanced In Vivo Therapeutic Screening Platform for T-ALL
2015
·
Vinothkumar Rajan
, Nicole Melong
, et al.
·
Blood
·
2
Abstract PR003: Canada’s path towards proteome guided therapies and advanced molecular pathology in pediatric precision oncology
2024
·
Georgina Barnabas
, Tariq Bhat
, et al.
·
Cancer Research
·
1
Abstract 4670: True bench-to-bedside science: An international pilot study modeling hard-to-cure pediatric cancers to prioritize therapeutic intervention
2023
·
Nadine Azzam
, Nicole Melong
, et al.
·
Cancer Research
·
1
86: Radiation Dose Enhancement Using Gold Nanoparticles with a Diamond Linear Accelerator Target: A Multiple Cell Type Analysis
2022
·
Olivia Piccolo
, Michael Ha
, et al.
·
Radiotherapy and Oncology
·
1
Abstract 3792: PAPSS1 (3’-phosphoadenosine 5’-phosphosulfate synthase 1) inhibition sensitizes non-small cell lung cancer to cisplatin treatment in vivo
2016
·
Ada W.Y. Leung
, Chansey J. Veinotte
, et al.
·
Cancer Research
·
1
Data from Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
2025
·
Nadine Azzam
, Jamie I. Fletcher
, et al.
Figure S1 from Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
2025
·
Nadine Azzam
, Jamie I. Fletcher
, et al.
Figure 3 from Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
2025
·
Nadine Azzam
, Jamie I. Fletcher
, et al.
Figure S3 from Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
2025
·
Nadine Azzam (21786706)
, Jamie I. Fletcher (14942868)
, et al.
·
Figshare
Figure 4 from Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
2025
·
Nadine Azzam
, Jamie I. Fletcher
, et al.
Figure S4 from Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
2025
·
Nadine Azzam (21786706)
, Jamie I. Fletcher (14942868)
, et al.
·
Figshare
Figure S2 from Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy
2025
·
Nadine Azzam (21786706)
, Jamie I. Fletcher (14942868)
, et al.
·
Figshare
Show more works
View as search
Works count:
78
Citation count:
250
H-index:
8
I10-index:
8
Year
Topic
Type
